ImaGenes, CLC Bio Ink Licensing Pact | GenomeWeb

NEW YORK (GenomeWeb News) – ImaGenes will provide its next-generation sequencing customers with a license to CLC Bio’s Genomics Workbench for sequence analysis applications under a new bundling agreement, CLC Bio said today.

ImaGenes Director of Bioinformatics and Services Steffen Henning said in a statement that the firm sought "a software platform which we could use to present our research results to our customers in an easy, coherent, and user-friendly way," and which would function with various next-generation sequencing platforms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.